SK
Stephanie Kenney
Chief Corporate Affairs OfficerMs. Stephanie Kenney is Chief Corporate Affairs Officer of Atrium Therapeutics, Inc. She has served as Senior Vice President, Corporate Affairs at Avidity since August 2025. Before joining Avidity, Ms. Kenney served as Vice President, Global Corporate Affairs & Investor Relations at Hansa BioPharma (Nasdaq: HNSA) from December 2022 to August 2025. Her earlier experience includes senior leadership positions at AstraZeneca (LSA: AZN), where she served as Global Head of Corporate Affairs for the Cardiovascular, Renal & Metabolic business between September 2020 and November 2022. Ms. Kenney holds a Bachelor of Science in Communications from Mansfield University.
Positions
- Company NameAtrium Therapeutics, Inc.Stock CodeRNAPositionChief Corporate Affairs OfficerColleagues
- KPKathleen P. GallagherPresident, CEO & Director
- SBSarah BoyceIndependent Chair of the Board of Director
- BWBrendan WinslowChief Financial Officer
- HYHusam YounisChief Scientific Officer
- SGSteven George HughesChief Medical Officer
- CBCarsten BoessIndependent Director
- TETroy Edward WilsonIndependent Director
- WMW. Michael F. FlanaganIndependent Director
